http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2020330592-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1847c0312d1a3fbcd82955f5512efbdd |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-507 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-31 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-1709 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-70503 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-4713 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-3955 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-18 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-17 |
| filingDate | 2018-10-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dcdfb426d02b36a64dca96f3b879f94f |
| publicationDate | 2020-10-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | US-2020330592-A1 |
| titleOfInvention | Compositions and methods of treating alzheimer's and other amyloid related diseases |
| abstract | The present disclosure relates to methods of treating, delaying the onset, alleviating a symptom, and/or deterring the progression of a disease related to beta amyloid deposits, neurological damage, tauopathy, and/or neurodegeneration by administering a myelin sheath protein and an antibody, such as an anti-tau antibody and/or an antibody that binds amyloid beta. The present disclosure relates to methods of using a myelin sheath protein and/or an antibody, such as an anti-tau antibody and/or an antibody that binds amyloid beta, to treat or to slow the progression of a disease characterized in part by beta amyloid (A) expression or activity, or by aberrant deposition of beta amyloid in a subject, such as in Alzheimers disease, and the pathologies associated with such a disease, including for example, behavioral changes or cognitive dysfunction associated with Alzheimers disease. |
| priorityDate | 2017-10-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 2015.